131 results
DEFA14A
EVOK
Evoke Pharma Inc
10 Apr 24
Additional proxy soliciting materials
3:35pm
C. Brady, M.D., Ph.D. 2. To consider and vote upon the ratification of the selection of BDO USA, P.C. as our independent registered public accounting
POS EX
EX-23.1
EVOK
Evoke Pharma Inc
14 Mar 24
Additional exhibits for listing
6:46pm
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Evoke Pharma, Inc.
Solana Beach, California
We hereby consent to the use
424B3
EVOK
Evoke Pharma Inc
14 Mar 24
Prospectus supplement
6:44pm
clinical trials may begin in the United States;
approval by an independent institutional review board, or IRB, at each clinical trial site before … Statements and Supplementary Data
Our financial statements and the report of our independent registered public accounting firm are included in this report
8-K
EX-4.1
el20u3l yw4ea6e8s3
14 Feb 24
Unregistered Sales of Equity Securities
9:00am
8-K
EX-1.1
fgs4f5p7
9 Feb 24
Evoke Pharma Announces Pricing of Underwritten Public Offering of up to $30 Million
5:15pm
424B4
itaz3os0tsntj1
9 Feb 24
Prospectus supplement with pricing info
5:14pm